AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INSULIN DEGLUDEC
8 registrations across 4 African markets— 8 active
Markets with INSULIN DEGLUDEC
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TRESIBA FLEXTOUCH (5X3ML) SOLUTION FOR INJECTION (INSULIN DEGLUDEC 100U/ML) | 🇬🇭Ghana | — | active | Apr 2030 |
| TRESIBA FLEXTOUCH | 🇬🇭Ghana | — | active | Apr 2030 |
| TRESIBA FLEXTOUCH | 🇬🇭Ghana | — | active | Apr 2030 |
| TRESIBA FLEXTOUCH (5X3ML) SOLUTION FOR INJECTION (INSULIN DEGLUDEC 100U/ML) | 🇬🇭Ghana | — | active | Apr 2030 |
| Tresiba FlexTouch 100U/mL** Solution for injection | 🇳🇬Nigeria | Novo Nordisk Pharma Ltd | active | Dec 2028 |
| Tresiba® FlexTouch® Solution For Injection | 🇰🇪Kenya | Novo Nordisk A/S | active | Jun 2027 |
| TRESIBA 100 U/ml | 🇿🇦South Africa | Novo Nordisk (Pty) Ltd û (Rivonia) | active | Jan 1900 |
| TRESIBA 200 U/ml | 🇿🇦South Africa | Novo Nordisk (Pty) Ltd û (Rivonia) | active | Jan 1900 |
INSULIN DEGLUDEC in Africa — Regulatory Overview
INSULIN DEGLUDEC is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, South Africa, Kenya, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.